Fulgent Genetics, Inc. ( FLGT) - Key Metrics
FLGT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.71 | -$0.76 | -$2.54 | -$2.70 |
| 2025Q3 | $2.73 | -$0.21 | $0.36 | $0.16 |
| 2025Q2 | $2.65 | -$0.61 | -$0.98 | -$1.20 |
| 2025Q1 | $2.38 | -$0.37 | -$0.14 | -$0.30 |
FLGT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.63 |
| 2025Q3 | ? | -26.29 |
| 2025Q2 | ? | -8.08 |
| 2025Q1 | ? | -11.30 |
FLGT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.39% | ? |
| 2025Q4 | -10.28% | ? |
| 2025Q3 | 0.73% | ? |
| 2025Q2 | -6.04% | ? |
| 2025Q1 | -1.76% | ? |
FLGT
Price: $18.14
52 week price:
Earnings Per Share: -2.40 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 235500
Ebitda: -1.0 millionMarket Capitalization: 515.2 million